Drug Database
Back to search

Netherlands· NL-0474b80ce6e9

Vincristinesulfaat Teva 1 mg/ml, oplossing voor injectie

A vincristine product containing vincristinesulfaat, registered in Netherlands by Teva B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC L01CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedVincristinesulfaat Teva 1 mg/ml, oplo…ATCL01CA02REGISTER NO.NL-0474b80ce6e9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vincristinesulfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vincristine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search vincristine products by name

Vincristine · ATC L01CA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
VINCRISTINESULFAAT
Manufacturer
Teva B.V.
Country
Netherlands (NL)
ATC code
L01CA02
ATC class
Vincristine
Defined daily dose
0.36 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    100081

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

583 interactions on record for vincristine.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check vincristine against other medicinesHow interaction checks work

Vincristine · interactions on record

583 records

  • 63 severe
  • 282 moderate
  • 25 minor
  • 213 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vincristine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vincristine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Oncovin, Vincristin Pfizer
  • Belgium · Vincrisin
  • Czechia · Vincristine Teva
  • Germany · Cellcristin, Vincristinsulfat Teva
  • Denmark · Oncovin
  • Spain · Vincristina Pfizer
  • Finland · Oncovin
  • France · Oncovin, Vincristine Hospira
  • United Kingdom (Northern Ireland) · Vincristine Sulfate Hospira Uk, Vincristine Sulfate Teva Uk
  • Ireland · Vincristine Sulfate Pfizer Healthcare Ireland
  • Italy · Vincristina, Vincristina Pfizer Italia
  • Lithuania · Vincristine Teva
  • Luxembourg · Vincrisin
  • Latvia · Vincristine Teva
  • Norway · Vincristine Pfizer
  • Poland · Vincristine Teva
  • Portugal · Vincristina Teva
  • Romania · Sindovin, Vincristină Teva
  • Sweden · Oncovin, Vincristine Pfizer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/40affba3-b00c-452f-976e-24c698036e3d
GET /v1/drugs/40affba3-b00c-452f-976e-24c698036e3d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100081_smpc.pdf",
  "strength": null,
  "atc_label": "Vincristine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100081",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZWAVELZUUR (E 513)"
  ],
  "substances": [
    "VINCRISTINESULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100081.pdf",
  "authorised_at": "2009/01/23",
  "procedure_number": "NL/H/1092/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "100081",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about vincristine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console